The 2nd Annual Gene Therapy Medical Affairs Summit is dedicated to exploring the pivotal internal
and external role Medical Affairs plays in delivering gene therapies to patients. This is your
opportunity to take inspiration from Medical Affairs leaders of the gene therapy world and learn
how traditional Medical Affairs approaches are being transformed to meet the unique challenges
associated with gene therapy drug development.
Gain actionable insights from first-to-market pioneers, who will share how to engage effectively with
internal clinical, commercial and regulatory teams as well as external HCPs, regulators and patient
advocates to create a cohesive and streamlined launch strategy for complex, high priced Gene
Therapy products.
The summit will provide a dedicated platform that discusses the role and value of Medical Affairs
across each of the phases of the gene therapy development cycle. We will delve into the unique
challenges encountered when working with gene therapies, from adapting to the clinical realities of
the rare disease space, to handling long-term follow up and post-launch regulatory scrutiny,
equipping you with the insights required to launch gene therapy products more efficiently and
effectively than ever before.
